Skip to main content

This job has expired

You will need to login before you can apply for a job.

Associate Director, Informatics

Employer
Intellia Therapeutics
Location
Cambridge, MA, United States
Start date
Dec 16, 2020

View more

Discipline
Science/R&D, Bioinformatics, Biology
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Genetown

Job Details

Our Mission: Developing curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

At Intellia, we are committed to solving the complex challenges of making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to create novel engineered cell therapies for immuno-oncological and autoimmune diseases.

Job Description:

Intellia Therapeutics is seeking an Associate Director of Informatics to support the development of CRISPR/Cas9 based therapeutics. This position is an opportunity to contribute to diverse aspects of Intellia's bioinformatics platform including overseeing the management of computational scientists and projects, working with bench scientists, and performing analyses of genomics datasets. Specifically, this position will focus on leading projects and people to perform computational analyses to aid in the development of cell therapies for immuno-oncology.

Responsibilities:

 

  • Develop and support NGS pipelines using commonly utilized tools (BWA, bowtie, samtools, etc.)
  • Apply rigorous statistical methods for testing hypotheses on processed data
  • Familiarity with SQL and the use of relational databases
  • Work with scientists to develop computational methods and tools to support new assays and implement data analyses
  • Create scientifically rigorous visualizations, communications, and presentations of results


Qualifications:

 

 

  • BS/MS in Bioinformatics or related field with 10+ years of industry experience
  • PhD in Bioinformatics or related field with 5+ years of industry experience
  • Experience managing computational scientists and projects
  • Demonstrated ability to write code in R, Python, Perl, or C++
  • Familiarity with Linux and shell scripting/bash
  • Experience processing and analyzing biological data, specifically sequencing data
  • Ability to translate user requirements into analysis pipelines or tools
  • Strong communication, time management, and presentation skills
  • Experience with software development in a cloud environment (AWS) is a plus
  • Preferred experience working with immuno-oncology or cancer genomics datasets

 


#LI-DG1

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

 

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert